COVID-19对血液静止的影响:凝血异常和管理观点
Emmanuel Ifeanyi Obeagu1, Muhammad Tukur2, Kingsley Akaba3
1Department of Medical Laboratory Science.
Annals of medicine and surgery (2012)
|October 3, 2024
概括
随着COVID-19的流行,血液凝固 (凝血病) 显著受到影响,影响疾病的严重程度和患者的治疗结果. 了解这些COVID-19相关的血液静止变化对于有效治疗和减轻血栓风险至关重要.
科学领域:
- * 内部医学 内部医学
- * 血液学 血液学
- * 传染病 传染病
背景情况:
- * 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 流行病已经揭示了除呼吸系统症状之外的重大影响.
- *COVID-19与凝血病有关,影响疾病的严重程度和预后.
- * 这些凝血异常带来复杂的临床管理挑战.
研究的目的:
- * 阐明COVID-19和血液静止之间的复杂关系.
- * 探索COVID-19中凝血障碍的机制.
- *讨论COVID-19相关的凝血病的发展管理策略.
主要方法:
- * 关于COVID-19和血液静止的当前文献的综述.
- * 对凝血异常的潜在机制的分析.
- *对血栓并发症和管理策略的检查.
主要成果:
- *COVID-19显著改变了血液静止和凝血路径.
- * 凝血病是COVID-19严重程度和预后的关键决定因素.
- *在COVID-19患者中观察到一系列的血栓性并发症.
结论:
- *全面了解COVID-19对血液静止的影响至关重要.
- *需要有效的管理策略来减轻血栓风险.
- * 进一步的研究对于完善诊断,确定治疗点以及了解长期后果至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


